Loading clinical trials...
Loading clinical trials...
Fluorescence-Guided Imaging of Brain Tumors: A Safety Study Using SBK2- ICG in a Phase 1 Clinical Trial
Conditions
Interventions
SBK2-ICG
Craniotomy (Standard of Care)
Locations
2
United States
University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center
Cleveland, Ohio, United States
Premier Health Neuroscience Institute
Dayton, Ohio, United States
Start Date
March 2, 2026
Primary Completion Date
November 1, 2026
Completion Date
December 31, 2026
Last Updated
February 27, 2026
NCT07539441
NCT03206060
NCT04065776
NCT05636618
NCT03050268
NCT05099003
Lead Sponsor
Tiffany Hodges
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions